Except OZZY you have omitted the very real possibility of a competing bid that forced Pfizer to raise their offer. Omission of the admission that BOD were not aware of any competing bid has just about popped the cat out of the bag IMHO. Take this scenario into account. DYOR
- Forums
- ASX - By Stock
- RAP
- My Analysis: No synergy value in valuation
My Analysis: No synergy value in valuation, page-29
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online